期刊
BIOMARKERS IN MEDICINE
卷 7, 期 2, 页码 205-210出版社
FUTURE MEDICINE LTD
DOI: 10.2217/BMM.12.107
关键词
ALT; AST; biomarkers; hepatitis B virus; hepatitis C virus; hepatocellular carcinoma; liver disease; microRNA; miR-122; tissue injury
Aim: Expression profiles indicate that miR-122 is specifically and abundantly expressed in liver. This study sought to determine miR-122 plasma concentrations in 15 apparently healthy subjects and 30 patients with liver disease, and clarify whether plasma miR-122 correlates with ALT. Materials & methods: miR-122 was measured by quantitative PCR in healthy volunteers and patients with liver disease. Results: ALT was increased in two out of 15 (13%) apparently healthy subjects and 17 out of 30(57%) liver disease patients. In healthy subjects, median miR-122 plasma concentration was 51.7 copies/20 pg RNA (range 16.0-312.0). In liver disease patients, median miR-122 was significantly elevated to 202.3 copies/20 pg RNA (range 20.9-1160.0; Mann Whitney test between median concentrations; p = 0.0016). Conclusion: This small proof-of-principle study suggests that miR-122 may be a potential plasma biomarker of liver damage.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据